Giovanni Magnaghi

Zambon Co. SpA operates as an industrial holding company with interests in pharmaceuticals and chemicals. The company was founded by Gaetano Zambon on November 11, 1906 and is headquartered in Bresso, Italy.

GEFIM SpA provides real estate investment and management services. The firm specializes in development, rehabilitation, and management of industrial spaces within urban cities and metropolitan areas. Its focuses on areas encompass project financing, economic feasibility studies, financial planning, administrative and technical support, and property acquisition. It also engages in contracting operations, focuses on the construction and design of industrial buildings and facilities. The company was founded by Cavaliere Paolo Ponchia in 1880 and is headquartered in Turin, Italy.

Enaz Srl functions as an investment holding Italian company. The private company is based in Milan, Italy.

Iava Srl is an investment holding Italian company. The private company is based in Milan, Italy.

Zambon Group SpA engages in the production of chemicals and medicines. The company was founded in 1906 and is headquartered in Bresso, Italy.

Secofind SIM SpA engages in the provision of investment services. It offers wealth protection, optimization, and management. The company was founded in 2000 and is headquartered in Milan, Italy.

Itaz Srl is an investment holding Italian company. The private company is based in Milan, Italy.

Part of Gefim SpA, Cleops SRL is an investment holding Italian company. The company is based in Milan, Italy.

Part of GEFIM SRL, Zambon Immobiliare SpA is an Italian company that provides real estate services. The company is based in Bresso, Italy.

Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy.

Part of IMAX Corp., IMAX Discovery GmbH develops novel and natural flavor compounds for the food and beverage industry. The company is based in Dortmund, Germany. The CEO of the German company is Alessandro Sidoli.

Euronext Growth Milan engages in the organization and management of the Italian stock exchange. Its activities include: overseeing transaction activities; defining the rules and procedures for admission and listing on the market for issuing companies, as well as for intermediaries; and the supervision of listed company disclosures. The company was founded in 1997 and is headquartered in Milan, Italy.

Bios SpA provides diagnostic laboratory services. The firm conducts multi-specialist medical treatment solutions through its facilities which include anti-thrombosis center, center for the diagnostic and treatment of hypertension, treatment of headache, and pregnancy monitoring center. It also provides emergency services through its department of emergency laboratory analysis and the service of rapid diagnostics as well as consultations on medicine in the workplaces, preventive medicine, and home care. The company was founded in 1974 and is headquartered in Rome, Italy.

Istituto Atesino di Sviluppo SpA (ISA) is a private equity firm founded in 1929. The firm is headquartered in Trento, Italy.

Cassa di Compensazione e Garanzia SpA engages in the provision of clearing and settlement services. It offers a broad range of trading venues and asset classes which include shares, warrants and convertible bonds listed on MTA market; stock, index futures and options listed on IDEM Equity; and closed-end funds. The company was founded on March 31, 1992 and is headquartered in Rome, Italy.

Castello SGR SpA (Castello) is an asset management firm headquartered in Milan, Italy. The firm was founded in 2007 and was acquired by Anima Holding SpA (BIT: ANIM) in 2023. Castello engages in the design and execution of real estate investment strategies for national and international investors who want to allocate their capital on the Italian real estate market. Investors of Castello SGR funds include financial institutions, insurance companies, private equity funds, hedge funds, pension funds, family offices, individual investors, both national and international. Castello is a signatory to the UN Principles for Responsible Investment (UNPRI).

Associazione fra le società italiane per azioni operates as an organization which deals with issues concerning the interests and the development of the Italian economy. Its activities deals with the improvement and promotion of problems and solutions in tax and legislation, corporate laws, business operations and competition, capital and listed company markets, economic analysis, and institutional reports. The company was founded on November 22, 1910 and is headquartered in Rome, Italy.

EuropeanIssuers operates as an an association representing the interests of publicly quoted companies. The company is headquartered in Brussels, Belgium.

Associazione Bancaria Italiana operates as a non-profit association to promote the principles of entrepreneurship and the creation of a free and competitive market to Italian banking and financial institutions and the civil society. It provides initiatives for the orderly growth, stability, and efficiency of the banking and financial industries such as economic studies, collaborations with national legislations, information activities, technical assistance, and consultancy. The company was founded on April 13, 1919 and is headquartered in Rome, Italy.

Valore Immobiliare Globale operates as a closed-end investment fund. Its objective is to promote and manage investment instruments for the real estate sector. The company was founded in November 1998 and is headquartered in Milan, Italy.

Externautics SpA provides biotechnology research and development services. The firms designs and manages platforms that identify and develop novel diagnostic and therapeutic markers for oncology applications. Its technology approach is based on the screening of libraries of polyclonal antibodies and recombinant proteins, generated from the corresponding human gene library of the poorly known membrane and secreted proteins. It focuses on the identification of membrane-exposed or serum circulating proteins whose presence associate to the frequent types of human tumors. The company was founded by Guido Grandi in 2007 and is headquartered in Siena, Italy.

Teatro alla Scala is an Italian company based in Milan that offers online ticket booking for opera, ballet, and concert performances. The private company's website also provides a program of the season's events and backstage photos and videos of the theater.

Primm SRL engages in the manufacturing, marketing and sale of biotech services. It offers poly and monoclonal antibodies, peptides, DNA synthesis, DNA sequencing, protein analysis, gene cloning, recombinant protein and pharmacological and toxicological services. The firm provides research and development activities which focuses on the design, synthesis, and pharmaceutical development of bioactive peptides for therapeutical applications. The company was founded by Sidoli Alessandro in 1990 and is based in Milan, Italy.

CDP Reti SpA operates as an investment company. The company was founded in October 2012 and is headquartered in Rome, Italy.

Part of The Goldman Sachs Group, Inc., Goldman Sachs Ltd. is an international merchant banking business. The company is based in London, UK. The CEOs of the British company are Philippe Louis Hubert Camu, Natasha Jhunjhunwala, Marie Lennon, Helen Moloney.

EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.

Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA.

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.